# Biologic Therapy to Prevent Osteoarthritis After ACL Injury

> **NCT03968913** · EARLY_PHASE1 · RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 32 (estimated)

## Conditions studied

- Anterior Cruciate Ligament Injuries

## Interventions

- **DRUG:** Anakinra injection
- **PROCEDURE:** sterile saline injection

## Key facts

- **NCT ID:** NCT03968913
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-15
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-01-26

## Collaborators

- Orthopedic Research and Education Foundation

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03968913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03968913, "Biologic Therapy to Prevent Osteoarthritis After ACL Injury". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT03968913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*